Nitriles-buliding-blocks

I found the field of Endocrinology & Metabolism very interesting. Saw the article Prevalence of diabetes and pre -diabetes in Greece. Results of the First National Survey of Morbidity and Risk Factors (EMENO) study published in 2021. COA of Formula: C8H9N, Reprint Addresses Makrilakis, K (corresponding author), Natl & Kapodistrian Univ Athens, Med Sch, Dept Propaedeut Med 1, Laiko Gen Hosp, 17 Ag Thoma St, Athens 11527, Greece.. The CAS is 95-11-4. Through research, I have a further understanding and discovery of 5-Norbornene-2-carbonitrile

Aims: To report the results of the first national Health Examination Survey (HES) on the prevalence of diabetes, its pharmacologic treatment and level of control, as well as pre -diabetes in Greece. Methods: Data were derived from the National Survey of Morbidity and Risk Factors (EMENO), in a randomly selected, representative sample of the adult Greek population. Sampling weights were applied to adjust for study design and post-stratification weights to match sample age/sex distribution to the population. Non-response was adjusted by inverse probability weighting. Weighted prevalence estimates are provided. Results: A total of 4393 persons with HbA1c and/or fasting plasma glucose measurements were included. Total diabetes prevalence was 11.9% (95% CI: 10.9-12.9), known diabetes 10.4% (9.5-11.4), and unknown 1.5% (1.1-1.9), with considerable increase in older age groups and no difference between genders. Pre-diabetes prevalence was 12.4% (11.4-13.6). The majority of persons with known diabetes were receiving metformin. Of those with known diabetes (and measured HbA1c), 70.9% were well controlled (HbA1c <7.0%). Conclusions: This first representative national HES showed high prevalence of diabetes in Greece, with low prevalence of unknown diabetes. Pre-diabetes prevalence is also substantial. These results will hopefully enable national authorities develop tailored and efficient strategies for disease prevention and management. COA of Formula: C8H9N. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Makrilakis, K; Kalpourtzi, N; Ioannidis, I; Iraklianou, S; Raptis, A; Sotiropoulos, A; Gavana, M; Vantarakis, A; Kantzanou, M; Hadjichristodoulou, C; Chlouverakis, G; Trypsianis, G; Voulgari, PV; Alamanos, Y; Touloumi, G; Liatis, S or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Authors Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S in KARGER published article about in [Bar-Or, Ruth Lev; Kor, Ariel; Lev-Ran, Shaul] Israel Ctr Addict ICA, Hazoran St 2, IL-4250602 Netanya, Israel; [Bar-Or, Ruth Lev] Hebrew Univ Jerusalem, Hadassah Sch Publ Hlth & Community Med, Jerusalem, Israel; [Kor, Ariel] Interdisciplinary Ctr IDC, Herzliyya, Israel; [Kor, Ariel] Yale Univ, Yale Sch Med, New Haven, CT USA; [Jaljuli, Iman] Tel Aviv Univ, Dept Stat & Operat Res, Tel Aviv, Israel; [Lev-Ran, Shaul] Lev Hasharon Med Ctr, Netanya, Israel; [Lev-Ran, Shaul] Tel Aviv Univ, Dept Psychiat, Sackler Fac Med, Tel Aviv, Israel in , Cited 51. Recommanded Product: 95-11-4. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4

Introduction: Substance use disorders (SUDs) are a leading cause of morbidity and mortality worldwide, having a profound and global impact on health, well-being, safety, and productivity. Although traditionally the prevalence of SUDs in Israel has been estimated to be lower than those in high-income countries, estimates and characteristics of individuals with SUDs in the past decade are lacking. In this work, we explored the prevalence of SUDs among the adult Jewish population in Israel, per different classes of substances across sex, age group, and other sociodemographic factors. Methods: Data from an online representative sample of 4,025 respondents were collected, including the alcohol, smoking, and substance involvement screening test (ASSIST) metric and sociodemographic data. Results: We found that the most common SUDs were alcohol (10.5% [9.5-11.4]), cannabis (9.0% [8.2-9.9]), and sedative (3.6% [3.0-4.2]) use disorders. Alcohol-cannabis (3.2% [2.7-3.7]) and alcohol-sedative (1.04% [0.7-1.35]) were the most prevalent co-occurring SUDs. Among those with cannabis use disorder, the prevalence of alcohol use disorder was found to be 35.3% [30.4-40.2]. The estimated risk for alcohol use disorder was found to be inversely proportional to age, cannabis use disorder increased, peaked, and decreased with age, and that of sedative use disorder increased with age, particularly among women. While older individuals (in the 51-60 years of age group) were at lower risk (OR = 0.5 [0.3, 0.8]) compared to those <20 years of age for alcohol use disorder, they were at increased risk for sedative use disorder (OR = 3.1 [1.2, 9.7]). Conclusions: These findings represent substantially higher rates of SUDs in Israel than those previously reported and should affect resources allocated to addiction prevention and treatment. Further research on the role of gender, age, culture, and ethnicity in the propensity to develop SUDs is necessary for the development of more focused preventive and intervention measures. Focusing on non-Jewish populations in Israel and broadening the scope to include behavioral addictions should be addressed in future studies. Recommanded Product: 95-11-4. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

An article Modular Dual-Tasked C-H Methylation via the Catellani Strategy WOS:000490358900033 published article about PALLADIUM-CATALYZED ALKYLATION; LATE-STAGE FUNCTIONALIZATION; AROMATIC FUNCTIONALIZATION; SELECTIVE ALKYLATION; COUPLING REACTIONS; ARYL IODIDES; REAGENTS; BONDS; ACTIVATION; NORBORNENE in [Gao, Qianwen; Shang, Yong; Song, Fuzhen; Ye, Jinxiang; Liu, Ze-Shui; Li, Lisha; Cheng, Hong-Gang; Zhou, Qianghui] Wuhan Univ, Engn Res Ctr Organosilicon Cpds & Mat, Sauvage Ctr Mol Sci, Coll Chem & Mol Sci,Minist Educ, Wuhan 430072, Peoples R China; [Zhou, Qianghui] Wuhan Univ, Inst Adv Studies, Wuhan 430072, Peoples R China in 2019, Cited 91. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4. Name: 5-Norbornene-2-carbonitrile

We report a dual-tasked methylation that is based on cooperative palladium/norbornene catalysis. Readily available (hetero)aryl halides (39 iodides and 4 bromides) and inexpensive MeOTs or trimethylphosphate are utilized as the substrates and methylating reagent, respectively. Six types of ipso terminations can modularly couple with this ortho C-H methylation to constitute a versatile methylation toolbox for preparing diversified methylated arenes. This toolbox features inexpensive methyl sources, excellent functional-group tolerance, simple reaction procedures, and scalability. Importantly, it can be uneventfully extended to isotope-labeled methylation by switching to the corresponding reagents CD3OTs or (CH3OTs)-C-13. Moreover, this toolbox can be applied to late-stage modification of biorelevant substrates with complete stereoretention. We believe these salient and practical features of our dual-tasked methylation toolbox will be welcomed by academic and industrial researchers.

Name: 5-Norbornene-2-carbonitrile. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Gao, QW; Shang, Y; Song, FZ; Ye, JX; Liu, ZS; Li, LS; Cheng, HG; Zhou, QH or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

An article Modular Dual-Tasked C-H Methylation via the Catellani Strategy WOS:000490358900033 published article about PALLADIUM-CATALYZED ALKYLATION; LATE-STAGE FUNCTIONALIZATION; AROMATIC FUNCTIONALIZATION; SELECTIVE ALKYLATION; COUPLING REACTIONS; ARYL IODIDES; REAGENTS; BONDS; ACTIVATION; NORBORNENE in [Gao, Qianwen; Shang, Yong; Song, Fuzhen; Ye, Jinxiang; Liu, Ze-Shui; Li, Lisha; Cheng, Hong-Gang; Zhou, Qianghui] Wuhan Univ, Engn Res Ctr Organosilicon Cpds & Mat, Sauvage Ctr Mol Sci, Coll Chem & Mol Sci,Minist Educ, Wuhan 430072, Peoples R China; [Zhou, Qianghui] Wuhan Univ, Inst Adv Studies, Wuhan 430072, Peoples R China in 2019, Cited 91. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4. Category: nitriles-buliding-blocks

We report a dual-tasked methylation that is based on cooperative palladium/norbornene catalysis. Readily available (hetero)aryl halides (39 iodides and 4 bromides) and inexpensive MeOTs or trimethylphosphate are utilized as the substrates and methylating reagent, respectively. Six types of ipso terminations can modularly couple with this ortho C-H methylation to constitute a versatile methylation toolbox for preparing diversified methylated arenes. This toolbox features inexpensive methyl sources, excellent functional-group tolerance, simple reaction procedures, and scalability. Importantly, it can be uneventfully extended to isotope-labeled methylation by switching to the corresponding reagents CD3OTs or (CH3OTs)-C-13. Moreover, this toolbox can be applied to late-stage modification of biorelevant substrates with complete stereoretention. We believe these salient and practical features of our dual-tasked methylation toolbox will be welcomed by academic and industrial researchers.

About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Gao, QW; Shang, Y; Song, FZ; Ye, JX; Liu, ZS; Li, LS; Cheng, HG; Zhou, QH or concate me.. Category: nitriles-buliding-blocks

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

COA of Formula: C8H9N. Authors Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S in KARGER published article about in [Bar-Or, Ruth Lev; Kor, Ariel; Lev-Ran, Shaul] Israel Ctr Addict ICA, Hazoran St 2, IL-4250602 Netanya, Israel; [Bar-Or, Ruth Lev] Hebrew Univ Jerusalem, Hadassah Sch Publ Hlth & Community Med, Jerusalem, Israel; [Kor, Ariel] Interdisciplinary Ctr IDC, Herzliyya, Israel; [Kor, Ariel] Yale Univ, Yale Sch Med, New Haven, CT USA; [Jaljuli, Iman] Tel Aviv Univ, Dept Stat & Operat Res, Tel Aviv, Israel; [Lev-Ran, Shaul] Lev Hasharon Med Ctr, Netanya, Israel; [Lev-Ran, Shaul] Tel Aviv Univ, Dept Psychiat, Sackler Fac Med, Tel Aviv, Israel in , Cited 51. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4

Introduction: Substance use disorders (SUDs) are a leading cause of morbidity and mortality worldwide, having a profound and global impact on health, well-being, safety, and productivity. Although traditionally the prevalence of SUDs in Israel has been estimated to be lower than those in high-income countries, estimates and characteristics of individuals with SUDs in the past decade are lacking. In this work, we explored the prevalence of SUDs among the adult Jewish population in Israel, per different classes of substances across sex, age group, and other sociodemographic factors. Methods: Data from an online representative sample of 4,025 respondents were collected, including the alcohol, smoking, and substance involvement screening test (ASSIST) metric and sociodemographic data. Results: We found that the most common SUDs were alcohol (10.5% [9.5-11.4]), cannabis (9.0% [8.2-9.9]), and sedative (3.6% [3.0-4.2]) use disorders. Alcohol-cannabis (3.2% [2.7-3.7]) and alcohol-sedative (1.04% [0.7-1.35]) were the most prevalent co-occurring SUDs. Among those with cannabis use disorder, the prevalence of alcohol use disorder was found to be 35.3% [30.4-40.2]. The estimated risk for alcohol use disorder was found to be inversely proportional to age, cannabis use disorder increased, peaked, and decreased with age, and that of sedative use disorder increased with age, particularly among women. While older individuals (in the 51-60 years of age group) were at lower risk (OR = 0.5 [0.3, 0.8]) compared to those <20 years of age for alcohol use disorder, they were at increased risk for sedative use disorder (OR = 3.1 [1.2, 9.7]). Conclusions: These findings represent substantially higher rates of SUDs in Israel than those previously reported and should affect resources allocated to addiction prevention and treatment. Further research on the role of gender, age, culture, and ethnicity in the propensity to develop SUDs is necessary for the development of more focused preventive and intervention measures. Focusing on non-Jewish populations in Israel and broadening the scope to include behavioral addictions should be addressed in future studies. COA of Formula: C8H9N. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Recently I am researching about SIMULATION; PERFORMANCE, Saw an article supported by the Agency for Health Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality. SDS of cas: 95-11-4. Published in LIPPINCOTT WILLIAMS & WILKINS in PHILADELPHIA ,Authors: Farra, SL; Gneuhs, M; Hodgson, E; Kawosa, B; Miller, ET; Simon, A; Timm, N; Hausfeld, J. The CAS is 95-11-4. Through research, I have a further understanding and discovery of 5-Norbornene-2-carbonitrile

Adoption of virtual reality technology may be delayed due to high up-front costs with unknown returns on that investment. In this article, we present a cost analysis of using virtual reality as a training tool. Virtual reality was used to train neonatal intensive care workers in hospital evacuation. A live disaster exercise with mannequins was also conducted that approximated the virtual experience. Comparative costs are presented for the planning, development, and implementation of both interventions. Initially, virtual reality is more expensive, with a cost of $229.79 per participant (total cost $18 617.54 per exercise) for the live drill versus $327.78 (total cost $106 951.14) for virtual reality. When development costs are extrapolated to repeated training over 3 years, however, the virtual exercise becomes less expensive with a cost of $115.43 per participant, while the cost of live exercises remains fixed. The larger initial investment in virtual reality can be spread across a large number of trainees and a longer time period with little additional cost, while each live drill requires additional costs that scale with the number of participants.

SDS of cas: 95-11-4. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Farra, SL; Gneuhs, M; Hodgson, E; Kawosa, B; Miller, ET; Simon, A; Timm, N; Hausfeld, J or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

In 2019 TOXICOL IN VITRO published article about BOVINE CORNEAL OPACITY; TIME EXPOSURE TEST; HPLC/UPLC-SPECTROPHOTOMETRY; HAZARD IDENTIFICATION; APPLICABILITY DOMAIN; CHEMICALS; ASSAY; VALIDATION in [Alepee, N.] LOreal Res & Innovat, Aulnay Sous Bois, France; [Adriaens, E.] Adriaens Consulting, Aalter, Belgium; [Abo, T.] Kao Corp, Safety Sci Res, Kawasaki, Kanagawa, Japan; [Bagley, D.] Colgate Palmolive Co, Piscataway, NJ USA; [Desprez, B.] Cosmet Europe Personal Care Assoc, Brussels, Belgium; [Hibatallah, J.] Chanel Parfums Beaute, Neuilly Sur Seine, France; [Mewes, K.] Henkel AG & Co KGaA, Dusseldorf, Germany; [Pfannenbecker, U.] Beiersdorf AG, Hamburg, Germany; [Sala, A.] Kao Corp SA, Barcelona, Spain; [Sala, A.] HP Inc, Barcelona, Spain; [Van Rompay, A. R.; Verstraelen, S.] VITO NV Flemish Inst Technol Res, Mol, Belgium; [McNamee, P.] Procter & Gamble Co, Egham, Surrey, England in 2019, Cited 36. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4. Formula: C8H9N

The focus of Cosmetics Europe’s programme on serious eye damage/eye irritation is on development of testing strategies and defined approaches for identification of ocular effects of chemicals in the context of OECD’s Guidance Document on an Integrated Approach on Testing and Assessment (IATA) for Serious Eye Damage and Eye Irritation. Cosmetics Europe created a comprehensive database of chemicals for which in vitro data are available with corresponding historical in vivo Draize eye data. This database allowed further exploration of the initially proposed strategies from the CON4EI project and to identify opportunities for refinement. The current analysis focused on the development of a defined approach, applicable to liquid non-surfactant chemicals, neat and in dilution, that can distinguish between the three UN GHS categories (Cat. 1, Cat. 2, and No Cat.). Combining the modified-protocol Short Time Exposure (STE) test method (OECD TG 491 with extension to highly volatile substances) with the Bovine Corneal Opacity and Permeability Laser Light-Based Opacitometer (BCOP LLBO) test method in a Bottom-Up approach identified 81.2% Cat. 1, 56.3% Cat. 2, and 85.3% No. Cat correctly, with an NPV of 96.7% and a PPV of 68.6%. Therefore, the performance of the defined approach was better than the standalone test methods.

Formula: C8H9N. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Alepee, N; Adriaens, E; Abo, T; Bagley, D; Desprez, B; Hibatallah, J; Mewes, K; Pfannenbecker, U; Sala, A; Van Rompay, AR; Verstraelen, S; McNamee, P or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Authors Alepee, N; Adriaens, E; Abo, T; Bagley, D; Desprez, B; Hibatallah, J; Mewes, K; Pfannenbecker, U; Sala, A; Van Rompay, AR; Verstraelen, S; McNamee, P in PERGAMON-ELSEVIER SCIENCE LTD published article about BOVINE CORNEAL OPACITY; TIME EXPOSURE TEST; HPLC/UPLC-SPECTROPHOTOMETRY; HAZARD IDENTIFICATION; APPLICABILITY DOMAIN; CHEMICALS; ASSAY; VALIDATION in [Alepee, N.] LOreal Res & Innovat, Aulnay Sous Bois, France; [Adriaens, E.] Adriaens Consulting, Aalter, Belgium; [Abo, T.] Kao Corp, Safety Sci Res, Kawasaki, Kanagawa, Japan; [Bagley, D.] Colgate Palmolive Co, Piscataway, NJ USA; [Desprez, B.] Cosmet Europe Personal Care Assoc, Brussels, Belgium; [Hibatallah, J.] Chanel Parfums Beaute, Neuilly Sur Seine, France; [Mewes, K.] Henkel AG & Co KGaA, Dusseldorf, Germany; [Pfannenbecker, U.] Beiersdorf AG, Hamburg, Germany; [Sala, A.] Kao Corp SA, Barcelona, Spain; [Sala, A.] HP Inc, Barcelona, Spain; [Van Rompay, A. R.; Verstraelen, S.] VITO NV Flemish Inst Technol Res, Mol, Belgium; [McNamee, P.] Procter & Gamble Co, Egham, Surrey, England in 2019, Cited 36. COA of Formula: C8H9N. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4

The focus of Cosmetics Europe’s programme on serious eye damage/eye irritation is on development of testing strategies and defined approaches for identification of ocular effects of chemicals in the context of OECD’s Guidance Document on an Integrated Approach on Testing and Assessment (IATA) for Serious Eye Damage and Eye Irritation. Cosmetics Europe created a comprehensive database of chemicals for which in vitro data are available with corresponding historical in vivo Draize eye data. This database allowed further exploration of the initially proposed strategies from the CON4EI project and to identify opportunities for refinement. The current analysis focused on the development of a defined approach, applicable to liquid non-surfactant chemicals, neat and in dilution, that can distinguish between the three UN GHS categories (Cat. 1, Cat. 2, and No Cat.). Combining the modified-protocol Short Time Exposure (STE) test method (OECD TG 491 with extension to highly volatile substances) with the Bovine Corneal Opacity and Permeability Laser Light-Based Opacitometer (BCOP LLBO) test method in a Bottom-Up approach identified 81.2% Cat. 1, 56.3% Cat. 2, and 85.3% No. Cat correctly, with an NPV of 96.7% and a PPV of 68.6%. Therefore, the performance of the defined approach was better than the standalone test methods.

COA of Formula: C8H9N. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Alepee, N; Adriaens, E; Abo, T; Bagley, D; Desprez, B; Hibatallah, J; Mewes, K; Pfannenbecker, U; Sala, A; Van Rompay, AR; Verstraelen, S; McNamee, P or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Application In Synthesis of 5-Norbornene-2-carbonitrile. Authors Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S in KARGER published article about in [Bar-Or, Ruth Lev; Kor, Ariel; Lev-Ran, Shaul] Israel Ctr Addict ICA, Hazoran St 2, IL-4250602 Netanya, Israel; [Bar-Or, Ruth Lev] Hebrew Univ Jerusalem, Hadassah Sch Publ Hlth & Community Med, Jerusalem, Israel; [Kor, Ariel] Interdisciplinary Ctr IDC, Herzliyya, Israel; [Kor, Ariel] Yale Univ, Yale Sch Med, New Haven, CT USA; [Jaljuli, Iman] Tel Aviv Univ, Dept Stat & Operat Res, Tel Aviv, Israel; [Lev-Ran, Shaul] Lev Hasharon Med Ctr, Netanya, Israel; [Lev-Ran, Shaul] Tel Aviv Univ, Dept Psychiat, Sackler Fac Med, Tel Aviv, Israel in , Cited 51. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4

Introduction: Substance use disorders (SUDs) are a leading cause of morbidity and mortality worldwide, having a profound and global impact on health, well-being, safety, and productivity. Although traditionally the prevalence of SUDs in Israel has been estimated to be lower than those in high-income countries, estimates and characteristics of individuals with SUDs in the past decade are lacking. In this work, we explored the prevalence of SUDs among the adult Jewish population in Israel, per different classes of substances across sex, age group, and other sociodemographic factors. Methods: Data from an online representative sample of 4,025 respondents were collected, including the alcohol, smoking, and substance involvement screening test (ASSIST) metric and sociodemographic data. Results: We found that the most common SUDs were alcohol (10.5% [9.5-11.4]), cannabis (9.0% [8.2-9.9]), and sedative (3.6% [3.0-4.2]) use disorders. Alcohol-cannabis (3.2% [2.7-3.7]) and alcohol-sedative (1.04% [0.7-1.35]) were the most prevalent co-occurring SUDs. Among those with cannabis use disorder, the prevalence of alcohol use disorder was found to be 35.3% [30.4-40.2]. The estimated risk for alcohol use disorder was found to be inversely proportional to age, cannabis use disorder increased, peaked, and decreased with age, and that of sedative use disorder increased with age, particularly among women. While older individuals (in the 51-60 years of age group) were at lower risk (OR = 0.5 [0.3, 0.8]) compared to those <20 years of age for alcohol use disorder, they were at increased risk for sedative use disorder (OR = 3.1 [1.2, 9.7]). Conclusions: These findings represent substantially higher rates of SUDs in Israel than those previously reported and should affect resources allocated to addiction prevention and treatment. Further research on the role of gender, age, culture, and ethnicity in the propensity to develop SUDs is necessary for the development of more focused preventive and intervention measures. Focusing on non-Jewish populations in Israel and broadening the scope to include behavioral addictions should be addressed in future studies. Application In Synthesis of 5-Norbornene-2-carbonitrile. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S or concate me.

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts

Authors Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S in KARGER published article about in [Bar-Or, Ruth Lev; Kor, Ariel; Lev-Ran, Shaul] Israel Ctr Addict ICA, Hazoran St 2, IL-4250602 Netanya, Israel; [Bar-Or, Ruth Lev] Hebrew Univ Jerusalem, Hadassah Sch Publ Hlth & Community Med, Jerusalem, Israel; [Kor, Ariel] Interdisciplinary Ctr IDC, Herzliyya, Israel; [Kor, Ariel] Yale Univ, Yale Sch Med, New Haven, CT USA; [Jaljuli, Iman] Tel Aviv Univ, Dept Stat & Operat Res, Tel Aviv, Israel; [Lev-Ran, Shaul] Lev Hasharon Med Ctr, Netanya, Israel; [Lev-Ran, Shaul] Tel Aviv Univ, Dept Psychiat, Sackler Fac Med, Tel Aviv, Israel in , Cited 51. Computed Properties of C8H9N. The Name is 5-Norbornene-2-carbonitrile. Through research, I have a further understanding and discovery of 95-11-4

Introduction: Substance use disorders (SUDs) are a leading cause of morbidity and mortality worldwide, having a profound and global impact on health, well-being, safety, and productivity. Although traditionally the prevalence of SUDs in Israel has been estimated to be lower than those in high-income countries, estimates and characteristics of individuals with SUDs in the past decade are lacking. In this work, we explored the prevalence of SUDs among the adult Jewish population in Israel, per different classes of substances across sex, age group, and other sociodemographic factors. Methods: Data from an online representative sample of 4,025 respondents were collected, including the alcohol, smoking, and substance involvement screening test (ASSIST) metric and sociodemographic data. Results: We found that the most common SUDs were alcohol (10.5% [9.5-11.4]), cannabis (9.0% [8.2-9.9]), and sedative (3.6% [3.0-4.2]) use disorders. Alcohol-cannabis (3.2% [2.7-3.7]) and alcohol-sedative (1.04% [0.7-1.35]) were the most prevalent co-occurring SUDs. Among those with cannabis use disorder, the prevalence of alcohol use disorder was found to be 35.3% [30.4-40.2]. The estimated risk for alcohol use disorder was found to be inversely proportional to age, cannabis use disorder increased, peaked, and decreased with age, and that of sedative use disorder increased with age, particularly among women. While older individuals (in the 51-60 years of age group) were at lower risk (OR = 0.5 [0.3, 0.8]) compared to those <20 years of age for alcohol use disorder, they were at increased risk for sedative use disorder (OR = 3.1 [1.2, 9.7]). Conclusions: These findings represent substantially higher rates of SUDs in Israel than those previously reported and should affect resources allocated to addiction prevention and treatment. Further research on the role of gender, age, culture, and ethnicity in the propensity to develop SUDs is necessary for the development of more focused preventive and intervention measures. Focusing on non-Jewish populations in Israel and broadening the scope to include behavioral addictions should be addressed in future studies. About 5-Norbornene-2-carbonitrile, If you have any questions, you can contact Bar-Or, RL; Kor, A; Jaljuli, I; Lev-Ran, S or concate me.. Computed Properties of C8H9N

Reference:
Patent; Mitsui Chemicals, Inc.; KUMA, Shigetoshi; SAKATA, Michiharu; TOKUNAGA, Kouichi; SHIMAKAWA, Chitoshi; KAKINUMA, Naoyuki; FURUYA, Masayuki; TANAKA, Mamoru; EP2708527; (2014); A1;,
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts